<DOC>
	<DOCNO>NCT00264394</DOCNO>
	<brief_summary>There grow evidence antiretroviral therapy ( ART ) increase risk coronary heart disease ( CHD ) metabolic side effect , dyslipidemia , insulin resistance , type II diabetes . Prevalence risk factor CHD HIV-infected individual receive ART Swiss HIV Cohort Study ( SHCS ) high . This cluster randomise control trial nest SHCS investigate whether physician randomise routine provision risk profile patient receive ART improve management risk factor HIV-infected patient compare control physicians routinely receive information . Risk profile generate SHCS data center provide clinician study center .</brief_summary>
	<brief_title>Cardiovascular Risk Factor Management HIV Infection</brief_title>
	<detailed_description>Evidence D.A.D . study , international cohort study include large proportion SHCS patient , suggest exposure antiretroviral therapy ( ART ) increase risk coronary heart disease ( CHD ) likely due ART induce metabolic change like dyslipidemia , insulin resistance , type II diabetes . The exact mechanism metabolic change whether specific class combination ART causally related change know . Of male age &lt; 40 &gt; 40 year SHCS , 8.8 % 32.5 % moderate ( 10 % - 20 % ) 1.7 % 6.9 % high ( â‰¥ 20 % ) risk CHD 10 year accord Framingham algorithm . The overall percentage moderate high 10-year risk CHD 14.9 % 3.0 % , respectively . Therefore , intervention reduce CHD risk among individual high risk CHD warrant . We propose randomise controlled cluster intervention trial reduce total cholesterol HIV-infected individual SHCS ( primary endpoint ) great equal 10 % 10 year risk CHD base Framingham score ( secondary endpoint ) . The intervention receipt structure continuously update information CHD risk factor treatment CHD risk factor HIV-infected patient . Randomisation do physician level stratify centre ( 7 centre SHCS , outpatient clinic hospital ) , size patient volume register private practice . For physician randomise intervention group , flow sheet information risk factor treatment status CHD provide patient every 6 month SHCS data centre . Each centre physician treat SHCS patient receive internationally locally approve guideline management risk factor CHD HIV-infected patient . The intervention limit 18 month . Our goal 7 % reduction total cholesterol ( primary endpoint ) intervention control group entire cohort . With alfa-error 5 % , power 80 % loss follow-up 10 % , 408 patient per arm need . Sample size calculation adapt cluster design trial show sufficient power detect 12 % reduction total cholesterol patient receive ART moderate high risk CHD . Further secondary endpoint reduction systolic diastolic blood pressure overall Framingham risk score . We additionally monitor whether change ART due high risk CHD , treatment CHD risk factor decrease proportion patient non-sustained control HIV-viremia . Data nest cluster trial provide important information whether provision individual 's CHD profile improve monitoring reduce CHD risk factor HIV-infected patient SHCS .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>For analysis primary endpoint : All individual SHCS age 18 old cohort visit 12 month precede randomisation date complete baseline dataset CHD risk factor For analysis secondary endpoint : All individual SHCS age 18 old cohort visit 12 month precede randomisation date complete baseline dataset CHD risk factor least 3 month ART moderate high risk CHD ( 10 % 10 year risk CHD accord Framingham risk score ) . Pregnant female Patients SHCS receive ART</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Computer generate reminder system</keyword>
	<keyword>quality control</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>antiretroviral therapy</keyword>
	<keyword>HIV infection</keyword>
</DOC>